SRR1381757
GTEX
Clinical attributes
From the source cohort, normalized into canonical keys plus the project's native columns.
- cancer_type
- GTEX
- cancer_type_detailed
- —
- subtype
- —
- cancer_type
- GTEX
- sex
- Male
GSVA pathway preview (0 Hallmark scores)
Top 10 most elevated and top 10 most suppressed Hallmark pathways for this sample.
Patient twins — nearest pathway neighbors
10 samples closest to this one in 50-dim pathway space, drawn from the Pathway Atlas. Cosine similarity = 1 means identical pathway state.
9 twins match this tumor's tissue · 1 come from a different tissue of origin
| # | Sample | Cancer type | Subtype | cos similarity |
|---|---|---|---|---|
| 1 | SRR1337412 | GTEX | — | 0.935 |
| 2 | SRR1341702 | GTEX | — | 0.932 |
| 3 | SRR1360744 | GTEX | — | 0.924 |
| 4 | SRR818057 | GTEX | — | 0.920 |
| 5 | SRR27320696 | — | — | 0.920 |
| 6 | BS_4BWB0FA0 | low-grade glioma | — | 0.914 |
| 7 | SRR1391639 | GTEX | — | 0.910 |
| 8 | 45b4921e-fce7-41f8-bb63-ed98343ceec8 | — | — | 0.903 |
| 9 | SRR1444622 | GTEX | — | 0.902 |
| 10 | SRR8392884 | — | cohortA1 | 0.900 |
Per-pathway drug coverage
For each elevated pathway in this tumor, the best-reversing drug across the catalog. Uncovered pathways = unmet need at pathway level for this one patient.
0 of 36 elevated pathways have at least one drug that meaningfully reverses them.
| Pathway (elevated) | tumor score | Best drug | reversal magnitude |
|---|---|---|---|
| TNFA_SIGNALING_VIA_NFKB | 0.503 | Inavolisib | — uncovered |
| EPITHELIAL_MESENCHYMAL_TRANSITION | 0.480 | Inavolisib | — uncovered |
| COAGULATION | 0.418 | Binimetinib | — uncovered |
| ESTROGEN_RESPONSE_LATE | 0.372 | Idelalisib | — uncovered |
| APOPTOSIS | 0.370 | Idelalisib | — uncovered |
| MYOGENESIS | 0.347 | Inavolisib | — uncovered |
| TGF_BETA_SIGNALING | 0.347 | Inavolisib | — uncovered |
| ANGIOGENESIS | 0.345 | Remibrutinib | — uncovered |
| INTERFERON_ALPHA_RESPONSE | 0.344 | Inavolisib | — uncovered |
| XENOBIOTIC_METABOLISM | 0.336 | Inavolisib | — uncovered |
| HYPOXIA | 0.329 | Idelalisib | — uncovered |
| IL6_JAK_STAT3_SIGNALING | 0.327 | Inavolisib | — uncovered |
| ADIPOGENESIS | 0.325 | Inavolisib | — uncovered |
| APICAL_SURFACE | 0.320 | Temsirolimus | — uncovered |
| INFLAMMATORY_RESPONSE | 0.318 | Idelalisib | — uncovered |
| ESTROGEN_RESPONSE_EARLY | 0.315 | Inavolisib | — uncovered |
| BILE_ACID_METABOLISM | 0.308 | Inavolisib | — uncovered |
| FATTY_ACID_METABOLISM | 0.295 | Inavolisib | — uncovered |
| HEDGEHOG_SIGNALING | 0.287 | Inavolisib | — uncovered |
| INTERFERON_GAMMA_RESPONSE | 0.277 | Idelalisib | — uncovered |